Recombinant Bovine MPV17L2 refers to a truncated form of the mitochondrial protein MPV17L2 (MPV17 mitochondrial membrane protein-like 2), expressed in mammalian cell systems. This recombinant protein is engineered for research purposes, enabling functional studies of its role in mitochondrial biology. MPV17L2 is a 206-amino-acid transmembrane protein localized to the inner mitochondrial membrane (IMM), where it interacts with mitochondrial ribosomal components and nucleic acids .
MPV17L2 is critical for mitochondrial ribosome assembly and mtDNA organization. Key findings include:
mtDNA Aggregation: MPV17L2 depletion induces nucleoid enlargement and mtDNA clustering, independent of mtDNA depletion .
mtRNA Stability: Reduced MPV17L2 expression impairs mitochondrial translation, as evidenced by diminished monosome levels and impaired protein synthesis .
MPV17L2 is linked to the Peroxisome pathway, though its primary role is mitochondrial. Related pathway components include:
MPV17L2’s inclusion in this pathway may reflect indirect regulatory interactions, though its core function resides in mitochondrial ribosome assembly .
Mitochondrial Disease Modeling: MPV17L2 knockdown mimics ribosomal defects seen in mitochondrial disorders, enabling studies of ribosome-nucleoid interactions .
Therapeutic Targeting: Insights into MPV17L2’s role in translation may inform strategies for mtDNA depletion syndromes, though direct therapeutic applications remain speculative.
Structural Studies: The recombinant protein facilitates biochemical assays (e.g., co-sedimentation, immunoprecipitation) to map ribosomal interactions .